Compounds > nicotine
Page last updated: 2024-08-26

nicotine and 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone

nicotine has been researched along with 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czachura, JF; Helton, DR; Kallman, MJ; Rasmussen, K1

Other Studies

1 other study(ies) available for nicotine and 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone

ArticleYear
The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle.
    Neuroreport, 1996, Apr-10, Volume: 7, Issue:5

    Topics: Animals; Hormone Antagonists; Male; Nicotine; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome

1996